About Future Pharmacology


Future Pharmacology (ISSN 2673-9879) is a peer-reviewed, open-access journal focusing on basic pharmacology, clinical pharmacology, drug discovery, and therapeutics; it aims to achieve a better understanding and dissemination of pharmacological sciences. The journal publishes full research papers, reviews, and communications. Authors are encouraged to publish their results in as much detail as possible. 


The scope covers but is not limited to the following topics: 

  • Drug design and discovery
  • Drug metabolism
  • Clinical pharmacology
  • Biochemical pharmacology
  • Cellular pharmacology
  • Molecular pharmacology
  • Drug–drug interactions
  • Neuropharmacology
  • Psychopharmacology
  • Drug misuse and addiction
  • Behavioral pharmacology
  • Toxicology
  • Pharmacogenetics
  • Pharmacogenomics
  • Biopharmaceuticals

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

St. Alban-Anlage 66
CH-4052 Basel

Copyright / Open Access

Articles published in Future Pharmacology will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

© 2024 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).


Reprints may be ordered. Please contact for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is .

Editorial Office

Contact us

For further MDPI contacts, see here.

Back to TopTop